Comparative clinical study of nemonapride, a benzamide compound with dopamine D2-like receptor blocking activity, and haloperidol in schizophrenic patients

Research Communications in Biological Psychology and Psychiatry

Volumn 24, Issue 1-2, 1999, Pages 35-46

  Zuoning, Jiang ^a   Zheng, Huang Shu ^a   Fu, Qin Ying ^a   Yamamoto, Minoru ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; EMONAPRIDE; HALOPERIDOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SINGLE BLIND PROCEDURE; SOMNOLENCE; XEROSTOMIA;

EID: 6744245569     PISSN: 10870695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Andreasen, N.C. (1983). The Scale for the Assessment of Negative Symptoms in Schizophrenia (SANS). University of Iowa. Iowa City, Iowa:
2. 3 receptors are elevated in schizophrenia and Alzheimer's (AD) cases. Soc Neurosci Abstr. 20:1169.
3. 4 receptors. Neurosci Lett 186:145-148.
4. 4 receptors. Br J Pharmacol. 117:1625-1632.
5. Kulkarni, S.K., Verma, A. (1993). Neuropharmacology of clozapine, an atypical antipsychotic. Drugs Today 29:469-475.
6. 2-family receptor distribution in human postmortem tissue: an autoradiographic study. Clin Neurosci Neuropathol. 6(18): 2505-2512.
7. Mori, A., Kazamatsuri, H., Kaneno, S., Kamijima, K., Kariya, T., Murasaki, M., Yagi, G. (1989). Double-blind comparison of a new benzamide compound of YM-09151 with haloperidol in the treatment of schizophrenia. Clin Eval. 17:349-377.
8. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci. 15(3):2186-2191.
9. Nishio, T. , Narita, M., Satoh, K. (1993). Immunocytochemical study on the effect of neuroleptics on proto-oncogene c-fos expression in the rat forebrain: Comparison nemonapride and haloperidol. Jap J Neuropsychopharmacol. 15(6):391-399.
10. Overall, J.E., Gorham, D.R. (1962). The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812.
11. Satoh, K., Someya, T., Shibasaki, M. (1996). Effects of nemonapride on positive and negative symptoms of schizophrenia. Int Clin Psychopharmacol. 11:279-281.
12. 4. Neuropsychopharmacol. 7, 261-284.
13. Seeman, P., Chau-Wong, M., Tedesco, J., Wong, K. (1975). Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci. 72:4376-4380.
14. 4 receptors are elevated in schizophrenia. Nature 365:441-445.
15. 3H]nemonapride. J Neurochem. 64(3)1413-1415.
16. 2 receptor binding to rat striatum. Eur J Pharmacol. 173:177-182.
17. Usuda, S., Nishikori, K., Noshiro, O., Maeno, H. (1981). Neuroleptic properteis of cis-N-(1-benzyl-2-methylpyrolidin-3-yl) -5- chloro- 2- methoxy- 4 -methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. Psychopharmacol. 73:103-109.
18. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
19. Yamamoto, M., Usudam, S., Tachikawa, S., Maeno, H. (1982). Pharmacological studies new benzamide derivative, YM-09151-2, with potential neuroleptic properties. Neuropharmacol. 21:945-951.